T cell factor-activated transcription is not sufficient to induce anchorage-independent growth of epithelial cells expressing mutant β-catenin

  1. Angela I. M. Barth,
  2. Daniel B. Stewart, and
  3. W. James Nelson
  1. Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305-5345
  1. Communicated by Elizabeth D. Hay, Harvard Medical School, Boston, MA (received for review November 6, 1998)

Abstract

N-terminal mutations in β-catenin that inhibit β-catenin degradation are found in primary tumors and cancer cell lines, and increased β-catenin/T cell factor (TCF)-activated transcription in these cells has been correlated with cancer formation. However, the role of mutant β-catenin in cell transformation is poorly understood. Here, we compare the ability of different N-terminal mutations of β-catenin (ΔN131, ΔN90, ΔGSK) to induce TCF-activated transcription and anchorage-independent growth in Madin–Darby canine kidney epithelial cells. Expression of ΔN90 or ΔGSK β-catenin increased TCF-activated transcription but did not induce significant anchorage-independent cell growth. In contrast, deletion of the α-catenin-binding site in ΔN131 β-catenin reduced TCF-activated transcription, compared with that induced by ΔN90 or ΔGSK β-catenin, but significantly enhanced anchorage-independent cell growth.

Footnotes

  • To whom reprint requests should be addressed. e-mail: angelab{at}leland.stanford.edu.

  • ABBREVIATIONS:
    TCF,
    T cell factor;
    APC,
    adenomatous polyposis coli;
    MDCK,
    Madin–Darby canine kidney;
    GSK,
    glycogen synthase kinase;
    Dox,
    doxycycline;
    −/+Dox,
    without or with Dox
« Previous | Next Article »Table of Contents